Patients with Blood Cancer & COVID-19

BCRWA @ The 63rd ASH Annual Meeting & Exposition 2021

Dr. Katharine Lewis to present Oral Abstract at ASH Annual Meeting 2021

Therapeutic Options for Relapsed/Refractory Mantle Cell Lymphoma

Professor Cheah ranked in the top 0.1% of lymphoma scholars globally

Non-Covalent BTK Inhibitors—The New BTKids on the Block for B-Cell Malignancies

Umbralisib Results from UNITY-NHL study published in the Journal of Clinical Oncology

Dr. Xuan Ni Tan Awarded a State Government Fellowship

Pirtobrutinib results (formerly known as LOXO-305) published in The Lancet Journal

Mosunetuzumab Shows Encouraging Results in Patients with High-Risk Follicular Lymphoma